In a groundbreaking collaboration between Zepto and the University of Minnesota, Zepto is pioneering a revolutionary multi-fungal detection system that has the potential to completely change the field of early infection diagnosis. In conjunction with the research team, led by Dr. Young at UMN, Zepto Life Technologies proprietary primer and probe design alongside unique GMR detection technology is put to the test in clinical molecular diagnostic testing.
About UMN Fareview
UMN Fairview, is a comprehensive healthcare system resulting from a partnership between the University of Minnesota, University of Minnesota Physicians, and Fairview Health Services. This collaboration, established to blend academic and community medicine, aims to expand access to advanced, breakthrough care across its network.
UMN Health Fairview operates 10 hospitals and over 60 clinics, offering a wide range of medical services and specialties. This partnership leverages the strengths of each entity to provide enhanced patient care, conduct innovative research, and offer top-tier medical education.
The system places a strong emphasis on integrating new medical technologies and methodologies into patient care, supporting its mission to improve health outcomes through collaborative and innovative approaches.
About Zepto Life Technology
Founded in 2014, Zepto Life Technology is a privately held company based in St. Paul, Minnesota. We are at the forefront of developing groundbreaking products that can detect invasive fungal infections using cell-free DNA found in blood. Our cutting-edge detection technology, Giant Magneto Resistance (GMR), is renowned for its high sensitivity and specificity. This Nobel Prize-winning technology from 2007 enables us to detect multiple infections accurately without compromising specificity.
In collaboration with Mayo Clinic, Zepto Life Technology is committed to advancing healthcare by providing precise and reliable diagnostic solutions.